Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 21 | $16,265,078 |
Sells | 1 | $3,526,971 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Nov 2023 16:37 | DMAC | DiaMedica Therapeutics Inc | WAMBEKE DAVID J. | Chief Business Officer | 16 Nov 2023 | Purchase | 20,000 | 2.46 | 49,200 | D |
01 Jul 2024 16:24 | DMAC | DiaMedica Therapeutics Inc | STAHLBERG JAN | 10% | 28 Jun 2024 | Purchase | 1,200,000 | 2.5 | 3,000,000 | I |
01 Jul 2024 16:27 | DMAC | DiaMedica Therapeutics Inc | VON KOCH THOMAS | 10% | 28 Jun 2024 | Purchase | 1,200,000 | 2.5 | 3,000,000 | I |
11 Apr 2023 17:40 | DMAC | DiaMedica Therapeutics Inc | WAMBEKE DAVID J. | Chief Business Officer | 10 Apr 2023 | Purchase | 468,750 | 1.6 | 750,000 | D |
12 Dec 2022 16:34 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 09 Dec 2022 | Purchase | 37,079 | 1.43 | 53,023 | D |
12 Dec 2022 16:34 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 08 Dec 2022 | Purchase | 20,000 | 1.4 | 28,000 | D |
08 Dec 2022 16:55 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 07 Dec 2022 | Purchase | 22,574 | 1.4 | 31,604 | D |
08 Dec 2022 16:55 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 06 Dec 2022 | Purchase | 2,300 | 1.35 | 3,105 | D |
06 Dec 2022 15:19 | DMAC | DiaMedica Therapeutics Inc | VON KOCH THOMAS | 10% | 02 Dec 2022 | Purchase | 2,855,847 | 1.235 | 3,526,971 | I |
06 Dec 2022 15:19 | DMAC | DiaMedica Therapeutics Inc | VON KOCH THOMAS | 10% | 02 Dec 2022 | Sale | 2,855,847 | 1.235 | 3,526,971 | I |
05 Dec 2022 16:16 | DMAC | DiaMedica Therapeutics Inc | PILNIK RICHARD D. | Director | 05 Dec 2022 | Purchase | 35,000 | 1.3855 | 48,492 | D |
05 Dec 2022 16:08 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 01 Dec 2022 | Purchase | 819 | 1.19 | 975 | D |
01 Dec 2022 17:11 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 01 Dec 2022 | Purchase | 46,133 | 1.2 | 55,360 | D |
01 Dec 2022 17:11 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 30 Nov 2022 | Purchase | 2,970 | 1.19 | 3,534 | D |
01 Dec 2022 17:11 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 29 Nov 2022 | Purchase | 18,125 | 1.19 | 21,569 | D |
27 Jun 2023 16:11 | DMAC | DiaMedica Therapeutics Inc | VON KOCH THOMAS | 10% | 23 Jun 2023 | Purchase | 1,470,588 | 3.4 | 4,999,999 | I |
26 Jun 2023 16:42 | DMAC | DiaMedica Therapeutics Inc | GIUFFRE RANDALL MICHAEL | Director | 23 Jun 2023 | Purchase | 65,000 | 3.91 | 254,150 | D |
26 Jun 2023 16:34 | DMAC | DiaMedica Therapeutics Inc | PAULS DIETRICH JOHN | President and CEO | 23 Jun 2023 | Purchase | 12,787 | 3.91 | 49,997 | D |
26 Jun 2023 16:26 | DMAC | DiaMedica Therapeutics Inc | SEMBA CHARLES PAULING | Director | 23 Jun 2023 | Purchase | 12,787 | 3.91 | 49,997 | D |
26 Jun 2023 16:21 | DMAC | DiaMedica Therapeutics Inc | KELLEN SCOTT | CFO and Secretary | 23 Jun 2023 | Purchase | 10,000 | 3.91 | 39,100 | D |
26 Jun 2023 16:14 | DMAC | DiaMedica Therapeutics Inc | WAMBEKE DAVID J. | Chief Business Officer | 23 Jun 2023 | Purchase | 38,364 | 3.91 | 150,003 | D |
26 Jun 2023 16:03 | DMAC | DiaMedica Therapeutics Inc | PILNIK RICHARD D. | Director | 23 Jun 2023 | Purchase | 38,363 | 3.91 | 149,999 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)